
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IPT-001
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Serum Institute of India
Deal Size : $11.7 million
Deal Type : Series A Financing
HERVolution Secures $11.7M Series A for Cancer and Aging Disease Treatments
Details : The financing will support the company-lead product IPT-001 to advance the clinical development for the treatment of HERVs prostate and pancreatic cancer.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
December 19, 2024
Lead Product(s) : IPT-001
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Serum Institute of India
Deal Size : $11.7 million
Deal Type : Series A Financing
